Gender differences in neuroleptic-refractory chronic schizophrenic dis
order patients were examined to determine whether a superior or equiva
lent antipsychotic response in women vs, men existed similar to that o
f the general schizophrenic population. Sixty-nine DSM-III schizophren
ic patients (47 males and 22 females) were treated with clozapine usin
g a standardized medication regime. The gender differences in these ne
uroleptic-nonresponsive chronic schizophrenic disorder patients differ
ed from those previously observed in the general schizophrenic populat
ion in that an equivalent antipsychotic treatment response in females
versus males was not found. These treatment-refractory women appear to
be a severely ill subgroup of female schizophrenics with distinct ons
et of illness, course and treatment response characteristics.